Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial
Year: 2002
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
Institutions: University Hospital Zurich, University of Hull, University of Freiburg, University Medical Center Freiburg, University of Szeged, University Medical Center Hamburg-Eppendorf, Kuopio University Hospital, Helsinki University Hospital, Max Planck Institute for Heart and Lung Research, London School of Hygiene & Tropical Medicine, Orion Corporation (Finland)
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2157204705
